BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 2590559)

  • 1. [Growth factors produced by rat glioma cells: activities of transforming growth factors].
    Kanno H; Shinonaga M; Kuwabara T; Umeda M
    No To Shinkei; 1989 Sep; 41(9):905-9. PubMed ID: 2590559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of transforming growth factors produced by the insulin-independent teratoma-derived cell line 1246-3A.
    Yamada Y; Serrero G
    J Cell Physiol; 1989 Aug; 140(2):254-63. PubMed ID: 2663884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of transforming growth factors by human colon cancer lines.
    Coffey RJ; Shipley GD; Moses HL
    Cancer Res; 1986 Mar; 46(3):1164-9. PubMed ID: 3002610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of growth responsiveness to epidermal growth factor and enhanced production of alpha-transforming growth factors in ras-transformed mouse mammary epithelial cells.
    Salomon DS; Perroteau I; Kidwell WR; Tam J; Derynck R
    J Cell Physiol; 1987 Mar; 130(3):397-409. PubMed ID: 3494020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of phorbol esters on the activity of purified transforming growth factors.
    Kraft AS
    Cancer Res; 1986 Apr; 46(4 Pt 1):1764-7. PubMed ID: 3004705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presence of transforming growth factors in human breast cancer cells.
    Salomon DS; Zwiebel JA; Bano M; Losonczy I; Fehnel P; Kidwell WR
    Cancer Res; 1984 Sep; 44(9):4069-77. PubMed ID: 6331663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth factor production by human colon carcinoma cell lines.
    Anzano MA; Rieman D; Prichett W; Bowen-Pope DF; Greig R
    Cancer Res; 1989 Jun; 49(11):2898-904. PubMed ID: 2541895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct high-performance liquid chromatography pattern of transforming growth factor activity in urine of cancer patients as compared with that of normal individuals.
    Kimball ES; Bohn WH; Cockley KD; Warren TC; Sherwin SA
    Cancer Res; 1984 Aug; 44(8):3613-9. PubMed ID: 6331653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification and biological properties of type beta transforming growth factor from mouse transformed cells.
    Fernandez-Pol JA; Klos DJ; Grant GA
    Cancer Res; 1986 Oct; 46(10):5153-61. PubMed ID: 3489522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction and modulation of anchorage-independent growth by platelet-derived growth factor, fibroblast growth factor, and transforming growth factor-beta.
    Rizzino A; Ruff E; Rizzino H
    Cancer Res; 1986 Jun; 46(6):2816-20. PubMed ID: 3457628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flat revertants derived from Kirsten murine sarcoma virus-transformed cells produce transforming growth factors.
    Salomon DS; Zwiebel JA; Noda M; Bassin RH
    J Cell Physiol; 1984 Oct; 121(1):22-30. PubMed ID: 6090475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of DNA synthesis in rat hepatocytes by platelet-derived type beta transforming growth factor.
    Carr BI; Hayashi I; Branum EL; Moses HL
    Cancer Res; 1986 May; 46(5):2330-4. PubMed ID: 3008986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor alpha and beta expression in human colon cancer lines: implications for an autocrine model.
    Coffey RJ; Goustin AS; Soderquist AM; Shipley GD; Wolfshohl J; Carpenter G; Moses HL
    Cancer Res; 1987 Sep; 47(17):4590-4. PubMed ID: 2887281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of epidermal growth factor/transforming growth factor-alpha-stimulated cell growth by a synthetic peptide.
    Eppstein DA; Marsh YV; Schryver BB; Bertics PJ
    J Cell Physiol; 1989 Nov; 141(2):420-30. PubMed ID: 2530243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factors produced by normal and neoplastically transformed rat liver epithelial cells in culture.
    Liu C; Tsao MS; Grisham JW
    Cancer Res; 1988 Feb; 48(4):850-5. PubMed ID: 3276400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presence of growth factors in human pituitary.
    Halper J; Parnell PG; Carter BJ; Ren P; Scheithauer BW
    Lab Invest; 1992 May; 66(5):639-45. PubMed ID: 1573857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of transforming growth factor-beta and epidermal growth factor on the cell cycle of cultured rabbit articular chondrocytes.
    Vivien D; Galéra P; Lebrun E; Loyau G; Pujol JP
    J Cell Physiol; 1990 Jun; 143(3):534-45. PubMed ID: 2358472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth factor-independent proliferation of rat mammary carcinoma cells by autocrine secretion of neu-differentiation factor/heregulin and transforming growth factor-alpha.
    Ethier SP; Langton BC; Dilts CA
    Mol Carcinog; 1996 Feb; 15(2):134-43. PubMed ID: 8599580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The purification of an acid- and heat-labile transforming growth factor from an avian sarcoma virus-transformed rat cell line.
    Yamaoka K; Hirai R; Tsugita A; Mitsui H
    J Cell Physiol; 1984 Jun; 119(3):307-14. PubMed ID: 6327732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suramin inhibition of growth factor receptor binding and mitogenicity in AKR-2B cells.
    Coffey RJ; Leof EB; Shipley GD; Moses HL
    J Cell Physiol; 1987 Jul; 132(1):143-8. PubMed ID: 3496343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.